Docetaxel and Immunotherapy Prior to Prostatectomy for High-Risk Prostate Cancer
Status:
Terminated
Trial end date:
2008-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find out what effects, good and bad, the combination of
docetaxel with CG1940/CG8711 (immunotherapy drugs) have on destroying prostate cancer before
removal the prostate (prostatectomy).